A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Harrow Health, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 29,300 shares of HROW stock, worth $1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,300
Previous 57,800 49.31%
Holding current value
$1 Million
Previous $1.21 Million 9.11%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$20.85 - $46.47 $594,225 - $1.32 Million
-28,500 Reduced 49.31%
29,300 $1.32 Million
Q2 2024

Aug 14, 2024

SELL
$10.0 - $21.64 $658,000 - $1.42 Million
-65,800 Reduced 53.24%
57,800 $1.21 Million
Q1 2024

May 15, 2024

SELL
$9.3 - $13.23 $279,000 - $396,900
-30,000 Reduced 19.53%
123,600 $1.64 Million
Q4 2023

Feb 14, 2024

SELL
$8.1 - $16.36 $427,680 - $863,808
-52,800 Reduced 25.58%
153,600 $1.72 Million
Q3 2023

Nov 14, 2023

SELL
$14.03 - $22.08 $620,126 - $975,935
-44,200 Reduced 17.64%
206,400 $2.97 Million
Q2 2023

Aug 14, 2023

SELL
$17.37 - $28.08 $1.03 Million - $1.66 Million
-59,100 Reduced 19.08%
250,600 $4.77 Million
Q1 2023

May 15, 2023

BUY
$13.84 - $21.46 $2.32 Million - $3.59 Million
167,300 Added 117.49%
309,700 $6.55 Million
Q4 2022

Feb 14, 2023

BUY
$10.28 - $14.78 $465,684 - $669,534
45,300 Added 46.65%
142,400 $2.1 Million
Q3 2022

Nov 14, 2022

SELL
$6.57 - $24.88 $217,467 - $823,528
-33,100 Reduced 25.42%
97,100 $1.17 Million
Q3 2022

Nov 14, 2022

SELL
$6.57 - $24.88 $217,467 - $823,528
-33,100 Reduced 25.42%
97,100 $1.17 Million
Q2 2022

Aug 15, 2022

BUY
$5.75 - $7.74 $101,775 - $136,998
17,700 Added 15.73%
130,200 $948,000
Q1 2022

May 16, 2022

SELL
$6.77 - $8.66 $285,165 - $364,776
-42,122 Reduced 27.24%
112,500 $767,000
Q4 2021

Feb 14, 2022

SELL
$8.5 - $12.0 $662,813 - $935,736
-77,978 Reduced 33.52%
154,622 $1.34 Million
Q3 2021

Nov 15, 2021

SELL
$6.99 - $10.6 $385,149 - $584,060
-55,100 Reduced 19.15%
232,600 $2.11 Million
Q2 2021

Aug 16, 2021

BUY
$6.68 - $11.07 $519,036 - $860,139
77,700 Added 37.0%
287,700 $2.67 Million
Q1 2021

May 17, 2021

BUY
$6.26 - $11.03 $517,702 - $912,181
82,700 Added 64.96%
210,000 $1.42 Million
Q4 2020

Feb 16, 2021

BUY
$4.76 - $6.93 $132,804 - $193,347
27,900 Added 28.07%
127,300 $873,000
Q3 2020

Nov 16, 2020

BUY
$4.71 - $7.36 $468,174 - $731,584
99,400 New
99,400 $556,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $926M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.